INS and type 2 diabetes mellitus: This effect could be mediated through protective mechanisms of obesity and hyperinsulinemia in diabetes type 2 on bone mass, since the strongest determinants of circulating levles of PAI-1 were insulin and tryglicerides leveles, thus prevailing over deleterious effect of chronic inflammation on bone metabolism (4,5).